共 30 条
Muscle volume alterations in spastic muscles immediately following botulinum toxin type-A treatment in children with cerebral palsy
被引:70
作者:
Williams, Sian A.
[1
]
Reid, Siobhan
[1
]
Elliott, Catherine
[2
]
Shipman, Peter
[3
]
Valentine, Jane
[4
]
机构:
[1] Univ Western Australia, Sch Sport Sci Exercise & Hlth, Perth, WA 6009, Australia
[2] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia
[3] Princess Margaret Hosp, Dept Diagnost Imaging, Perth, WA, Australia
[4] Princess Margaret Hosp, Dept Paediat Rehabil, Perth, WA, Australia
关键词:
SKELETAL-MUSCLE;
ADVERSE EVENTS;
GASTROCNEMIUS-MUSCLE;
LOWER-EXTREMITY;
INJECTION;
MORPHOLOGY;
STATEMENT;
EFFICACY;
GROWTH;
SAFETY;
D O I:
10.1111/dmcn.12200
中图分类号:
R74 [神经病学与精神病学];
学科分类号:
摘要:
\AIM With evidence for an atrophic effect of botulinum toxin type A (BoNT-A) documented in typically developing muscles, this study investigated the immediate morphological alterations of muscles in children with cerebral palsy (CP) after BoNT-A treatment. METHOD Fifteen children (10 males, five females; age range 5-11y, mean age 8y 5mo, SD 1y 10mo) with spastic diplegic CP [Gross Motor Function Classification System Levels I (n=9) and II (n=6)] receiving BoNT-A injections for spasticity management were included. None of the children was a first-time receiver of BoNT-A. Magnetic resonance imaging and Mimics software assessed muscle volume, timed 2 weeks before and 5 weeks after injection. All participants received BoNT-A bilaterally to the gastrocnemius muscle, and five participants also received BoNT-A bilaterally to the medial hamstring muscles. Functional assessment measures used were the 6-Minute Walk Test (6-MWT), the Timed Up and Go (TUG) test, and hand-held dynamometry. RESULTS Whilst total muscle group volume of the injected muscle group remained unchanged, a 4.47% decrease in the injected gastrocnemius muscle volume (p=0.01) and a 3.96% increase in soleus muscle volume (p=0.02) was evident following BoNT-A. There were no statistically significant changes in function after BoNT-A as assessed by the TUG. There was also no statistically significant change in distance covered in the 6-MWT. Muscle strength, as assessed using hand-held dynamometry was also not statistically different after BoNT-A treatment. INTERPRETATION Muscle volume decreases were observed in the injected muscle (gastrocnemius), with synergistic muscle hypertrophy that appeared to compensate for this decrement. The 4% to 5% decrease in the volume of BoNT-A injected muscles are not dramatic in comparison to reports in recent animal studies, and are a positive indication for BoNT-A, particularly as it also did not negatively alter function.
引用
收藏
页码:813 / 820
页数:8
相关论文